1-substituted 4-arylpiperazine as kappa opioid receptor antagonists
US9512105B2 · kind B2 · utility
0Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2012 |
| Grant date | Dec 6, 2016 |
| Priority date | — |
| Expiry date | Dec 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds represented by the formula: where R, Y3, R1, R2, R3, R4, R6, G, R7, E1, E2, A, B, W, X, Y and Z are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.